Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Fig. 2

BCA attenuated histomorphological damage of murine db/db-induced osteoporosis with T2DM. Representative H&E (A) and TRAcP (B) staining images of the proximal tibia (Scale bars = 50 μm). C The quantifications of Oc.S/BS were calculated based on TRAcP staining by using the Image J software. (Data were presented as mean ± SD. Significant differences between the Model and other groups were shown as ** (p-value < 0.01), *** (p-value < 0.001))

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us